Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18–64 years in BCBS of Texas-Reference-Cited by-同舟云学术

Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18–64 years in BCBS of Texas

Published:2018-02-08 Issue:3 Volume:169 Page:573-586
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Kim Junghyun^ORCID,Rajan Suja S.,Du Xianglin L.,Franzini Luisa,Giordano Sharon H.,Morgan Robert O.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-018-4704-3/fulltext.html

Reference36 articles.

1. Yung RL, Hassett MJ, Chen K, Gesten FC, Roohan PJ, Boscoe FP et al (2012) Initiation of adjuvant hormone therapy by medicaid insured women with nonmetastatic breast cancer. J Natl Cancer Inst 14:1102–1111

2. Owusu C, Buist DSM, Field TS, Lash TL, Thwin SS, Geiger AM et al (2008) Predictors of tamoxifen discontinuation among older women with estrogen receptor—breast cancer. J Clin Oncol 26:549–555

3. Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY et al (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8769 early-stage breast cancer patients. J Clin Oncol 28:4120–4128

4. Vrijens France, Stordeur Sabine, Beirens Koen, Devriese Stephan, Van Eycken Elizabeth, Vlayen Joan (2012) Effect of hospital volume on processes of care and 5-year survival after breast cancer: a population-based study on 25000 women. The Breast 21(3):261–266

5. Measring the Quality of Cancer Care. The National Initiative for Cancer Care Quality (NICCQ). 2006. RAND. www.rand.org as a public service of the RAND Corporation

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between Nurses’ Perceptions and Financial Toxicity Management in the Public Health Insurance System;Future Oncology;2024-02

2. Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives;Breast Cancer;2023-06-13

3. Factors Associated with Financial Toxicity in Patients with Breast Cancer in Japan: A Comparison of Patient and Physician Perspectives;2023-05-04

4. Economic burden of cancer treatment in India: an equity perspective;Journal of Social and Economic Development;2023-04-28

5. Geographic Variations and the Associated Factors in Adherence to and Persistence with Adjuvant Hormonal Therapy for the Privately Insured women Aged 18–64 with Breast Cancer in Texas;Current Oncology;2023-03-29